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Abstract Cytokines are extremely potent biomole-
cules that regulate cellular functions and play multiple
roles in initiation and inhibition of disease. These
highly specialised macromolecules are actively
involved in control of cellular proliferation, apoptosis,
cell migration and adhesion. This work, investigates
the effect of transforming growth factor-beta2 (TGF-
b2) on the biological regulation of chondrocyte and
the repair of a created model wound on a multilayer
culture system. Also the effect of this cytokine on cell
length, proliferation, and cell adhesion has been
investigated. Chondrocytes isolated from knee joint
of rats and cultured at 4 layers. Each layer consisted of
2 9 105 cells/ml with and without TGF-b2. The
expression of mRNA and protein levels of TGF-b
receptors and Smad1, 3, 4, and 7 have been analysed
by RT-PCR and western blot analysis. The effect of
different supplementations in chondrocyte cell prolif-
eration, cell length, adhesion, and wound repair was
statistically analysed by One-way ANOVA test. Our
results showed that the TGFb2 regulates mRNA levels
of its own receptors, and of Smad3 and Smad7. Also
the TGF-b2 caused an increase in chondrocyte cell
length, but decreased its proliferation rate and the
wound healing process. TGF-b2 also decreased cell
adhesion ability to the surface of the culture flask.
Since, TGF-b2 increased the cell size, but showed
negative effect on cell proliferation and adhesion of
CHC, the effect of manipulated TGF-b2 with other
growth factors and/or proteins needs to be investigated
to finalize the utilization of this growth factor and
design of scaffolding in treatment of different types of
arthritis.
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HBSS Hank’s balanced salt solution
RT-PCR Real time-polymerase chain reaction
FCS Fetal calf serum
ELISA Enzyme-linked immunosorbent assay
ACI Autologous chondrocyte implantation
RAC Rat articular chondrocytes (RAC)
HAC Human articular chondrocyte (HAC)
Introduction
Cartilage degeneration caused by injuries and con-
genital abnormalities is a great clinical challenge
(Gillogly et al. 1998). Damage to cartilage results an
incomplete wound healing and can be followed by
progressive and chronic lesions (Bhosale and Richard-
son 2008). Cartilage can be injured by tears, general
wear or injury resulting from genetic factors or
overuse of tissue during sport (McIlwraith 2007).
Damage to the cartilage does initiate a reparative
response (Meyer and Wiesmann 2006). However,
deep cartilage defects result in the loss of non-
collagenous matrix (Meyer and Wiesmann 2006)
which requires complete tissue repair and in more
severe cases when the lesion is in the fibrillar network
and involves significant cell death the cartilage does
not heal (Cubinskaya et al. 2008). In contrast if a lesion
occurs in the collagenous matrix, there is a degree of
regeneration. In this case treatment of cartilage by a
cell therapy method and engineered tissue could
enhance tissue repair (Cohen et al. 1992).
Cytokines are group of macromolecules synthe-
sized by cells in response to immune stimuli to
regulate the cell’s function (Galvani and Cowley
1992). They exert their effects on the same cells
(autocrine activity) or on the neighboring cells
(paracrine activity) by interacting with specific recep-
tors (Balkwill 2000; Kermani and Pham 2001).
Cytokines act as signaling proteins, and like hormones
play an important role in pathophysiological and
homeostatic processes such as fever, wound healing,
inflammation, tissue repair and fibrosis. They are very
active in regulation of cell function such as prolifer-
ation, migration, and matrix synthesis (Maitre et al.
2007). Some diseases such as degeneration of inter-
vertebral disks could be caused by altering the
expression of cytokines such as Interleukin-1 (IL-1)
(Raftery and Sutherland 2002). Therefore investiga-
tion the role of cytokines in the development of
diseases could be helpful in the therapy of some
disorders.
Transforming growth factor-b (TGF-b) superfam-
ily includes a large group of soluble extracellular
proteins which regulate the development in both
vertebrates and invertebrates (Krauss 2006; Soo
et al. 2000). TGF-b family regulates the cell functions
such as migration, apoptosis, proliferation and differ-
entiation (Stoff et al. 2007; Soo et al. 2000; Spagnoli
et al. 2007).
Transforming growth factor-b (TGF-b1, 2, and 3)
has been implicated in the ontogenetic transition from
scarless fetal repair to adult skin repair with scaring.
Fibromodulin which is a member of the small leucine-
rich proteoglycan family has been suggested as a
biologically significant mediator of fetal scarless
repair (Han et al. 2007; Cailotto et al. 2007). There
is evidence that fibromodulin may be a biologically
relevant modulator of TGF-b activity during scar
formation (Tchetina et al. 2006). Spagnoli et al. (2007)
studied the role of transforming growth factor b (TGF-
b) signalling in mice lacking the TGF-b type-II
receptor gene in their limbs. They found that TGF-b
receptor II signalling regulates growth and differen-
tiation factor-5 (GDF-5) and joint morphogenic gene
expression (Okazaki et al. 1996). Han et al. (2007) also
studied the effect of transforming growth factor-b1 on
regulation of fibronectin isoform expression and
splicing factor SRp40 expression during pro-chondro-
genic cell line (ATDC5) chondrogenic maturation.
Their report showed that the effects of TGF-b1 on
fibronectin isoform splicing during chondrogenesis
may be largely dependent on its effect on SRp40
isoform expression (Thorp et al. 1992).
Cailotto et al. (2007) examined the production of
extracellular inorganic pyrophosphate (ePPi) in chon-
drocytes and the signalling pathways involved in the
regulation of Ank gene expression by TGF-b. The
outcome of their research shows that the TGF-b
increases ePPi level, mainly by the induction of the
Ank gene, which requires activation of Ca2?-
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dependent Protein Kinase C (PKC) pathways in
chondrocytes (Yamashita et al. 2002). Mutations in
the Ank gene were reported in autosomal dominant
craniometaphyseal dysplasia and ankylosing
spondylitis, supporting a key role for the Ank gene
in the field of mineralizing arthropathy (Galvani and
Cowley 1992; Kaiser et al. 2004).
Biological effect of TGF-b are mediated by two
different serine/threonine kinase receptors, named
TbRI and TbRII and important for inducing signal
transduction. TbRI phosphorylates the receptor-regu-
lated Smads (R-Smads) Smad2 and Smad3, which
bind to Smad4, translocate into the nucleus and
regulate gene expression in concert with other tran-
scriptional factors (Davidson et al. 2005). Like
R-Smads, the inhibitory Smad7 interacts with the
activated TbRI receptor. In contrast to Smad2/3,
Smad7 forms a stable association with the receptor
complex and prevents receptor-mediated phosphory-
lation of pathway-restricted Smads, resulting in
disruption of TGFb signaling. TGF-b signalling
pathway plays a critical role for maintenance of tissue
homeostasis, and modification of TGF-b signaling
gene expression may be a cause for articular diseases
such as osteoarthritis (OA) (Oka et al. 2007). Smad3
gene mutations are associated with the pathogenesis of
it (Pohlers et al. 2007). In addition, osteoarthritis is
associated with modifications of TbRII and Smad7
expression (Ferguson and O’Kane 2004).
Tchetina et al. (2006) examined the effect of TGF-
b2 on collagen cleavage on human osteoarthritic
cartilage (Gorvy et al. 2005). Before Tchetina et al.,
Okazaki et al. (1996) studied the effects of transform-
ing growth factor beta-1, beta-2 and basic fibroblast
growth factor (bFGF) on articular chondrocytes
obtained from immobilised rabbit knees. However,
they did not use TGF-beta 3. They reported that the
TGF beta-1 or TGF beta-2 in combination with bFGF
exerted synergistic effects on cell proliferation in
articular chondrocytes obtained from the rabbit. Their
results suggest a critical role of cytokine combinations
in the development of articular cartilage degeneration
after immobilisation (Liu et al. 2014). Thorp et al.
(1992) reported on the effects of transforming growth
factor-beta 1, -beta 2 and -beta 3 in cartilage and bone
cells during endochondral ossification in the chick.
They discovered that TGF-beta localization controlled
an increase in type II collagen and mRNA expression
in transitional chondrocytes, suggesting a role for
TGF-beta in the induction of synthesis of extracellular
matrix (Khaghani et al. 2012).
Yamashita et al. (2002) used fibroblast growth
factor-2 (FGF-2) to determine severity of joint disease
in Adjuvant-Induced arthritis in rats. Their results
suggested that FGF-2 modulated disease progression,
but did not affect initiation of the arthritis (Sefat et al.
2016).
As shown above there are many reports regarding
using of various cytokines, growth factors and devel-
oped chondrocyte culture methods to stimulate the
chondrocyte proliferation in vivo and in vitro. How-
ever, until now there are very few reports looking at
the effect of the transforming growth factor beta
family of cytokines (TGF-b1, TGF-b2 and TGF-b3)
on chondrocyte cell–cell and cell–ECM adhesion, cell
proliferation, migration and wound healing.
Davidson et al. (2005) investigated the change of
transforming growth factor-beta signalling in cartilage
of old mice and found that the TGF-b2 and 3 were
reduced in 2 year old mice in comparison to 5 months
old animals. The conclusion of their reports shows that
the TGF-beta appears to play an important role in
repair of cartilage and a lack of TGF-beta responsive-
ness in old mice might be at the root of osteoarthritis
(Zheng et al. 2016).
Oka et al. (2007) used TGF-b2 to examine the role
of TGF-b signalling in regulation of chondrogenesis
and osteogenesis during mandibular development.
Their data suggested that there are differential signal
flows in response to TGF-b control of chondrogenesis
and osteogenesis during mandibular development
(Lawrence 2001).
Pohlers et al. (2007) published a paper about up-
regulation of the transforming growth factor-b path-
way in rheumatoid arthritis (RA). They reported that
the pathogenetic role of TGF-b-induced effects on
Synovial Fibroblast (SFBs) in RA (Docagne et al.
2004).
The importance of transforming growth factors in
wound healing has caused significantly increase in
research on these types of cytokines.
Related work was also carried out by Mark
Ferguson and O’Kane (2004) who identified some
TGF-b1 related therapeutic targets. They found that
the growth factor profiles differ significantly in
embryonic and adult tissue. For example, levels of
TGF-b1 and TGF-b2 in embryonic wounds are very
low, however the levels of TGF-b3 is much higher in
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comparison to adult wounds (Van der Kraan and Van
den Berg 2008). Similarly, Gorvy et al. (2005) found
that by inhibiting TGF-b1 and TGF-b2, whilst simul-
taneously increasing TGF-b3 concentrations in adult
wounds, near embryonic repair could be achieved in
adults (Yao et al. 2003).
Noticeably significant research on chondrocyte
adhesion is lacking. In this work cell response in
terms of cell phenotype, adhesion, alignment, wound
healing capacity and secretion of extracellular matrix
molecules will be examined in relation to exposure to
TGF-b2 in multiple 2 dimensional (Multilayer 3D)
culture systems.
Materials and methods
Primary chondrocyte culture
Six neonate Sprague–Dawley rats were euthanized
according schedule-1 of euthanasia. The Hyaline
cartilages from knee joints were harvested, and their
extracellular matrix was digested for 45 min at 37 C
using 15 ml Trypsin EDTA-0.25% and 10 ml Colla-
genase type-II (Sigma Aldrich, UK). The cell suspen-
sion was centrifuged at 550 g to separate the cells from
solution. The supernatant was discarded and the cell
pellte were re-suspended in 5 ml-high glucose Dul-
becco’s modified eagle’s medium (DMEM) (Sigma
Aldrich, UK) with 1% L-glutamine supplementation.
In 5 ml cell suspension 14 9 105 cells were counted
using a haemocytometer, giving a cell density of
2.8 9 105 cells/ml. The cell suspension was kept in a
15 ml centrifuge tube and incubated at 37 C until
preparation of a TGF-b2 solution.
Addition of this growth factor to the culture media
facilitated the investigation of the effects of TGF-b2
on the chondrocyte cell length, proliferation rate, cell
adhesion and on wound repair of the created wound
model.
All results from each part of the experiment were
standardised using the setting of the initial cell density
as 100% and then comparing the remaining cells with
initial percentage. Standard error (± SE) is also used
to estimate any error in measurements and to deter-
mine the accuracy of the results.
Reconstitution of TGF-b2
TGF-b2 is a multifunctional peptide soluble in acid
solvent. It is also soluble in water; however, the
solution would be sticky and difficult to aliquot and
utilise. It is also evident that TGF-b2 requires a carrier
molecule such as BSA to enable cell uptake by cell
(Spagnoli et al. 2007). Several TGF-b2 with different
concentrations (5, 10 and 50 ng/ml) were used previ-
ously in our research while measuring the percentage
of wound closure for chondrocyte mono and multi-
layers. Therefore a stock solution of 5 lg/ml TGF-b2
was made by dissolving 2 lg of TGF-b2 in 400 ll of
sterile 4 mM HCl containing 1 lg/ml BSA (Spagnoli
et al. 2007; Zhang et al. 2007).
Primary chondrocyte culture
The experiment consisted of five tissue culture flasks
labeled as Control, HCl, HCl/BSA, BSA and TGF-b2.
A total of 2.88 9 105 cells per culture flask were
subjected to this set of experiments. By resuspending
this amount of cells into 5 ml cell culture media, each
culture flask is supposed to have a cell density of
5.76 9 104 cells/ml.
A total of 5 ml of cell suspension were poured into
the culture flask labeled as control. A total of 10 ll of
4 mM HCl was added into another 5 ml cell suspen-
sion labeled as HCl. 10 ll of BSA solution, dissolved
in sterilised distilled water with a concentration of
1.5 lg/ml, added into 5 ml cell suspension and poured
into the cell culture flask labeled as BSA. Another
5 ml cell suspension was supplemented with 10 ll of
4 mM BSA/HCl prepared earlier and transferred into
the culture flask named as BSA/HCl. The final 5 ml
cell suspension was supplemented with 10 ll TGF-b2
solution, poured into the culture flask labeled as TGF-
b2 and incubated at 37 C with another four culture
flasks. Every 24 h the cell cultures were checked and
imaged using a phase-contrast microscope with
10 9 magnification. The images were saved for future
reference. Also, every 48 h, the media were aspirated,
discarded and replaced with fresh media with the same
(10 ll/ml v/v) TGF-b2 supplementation (Fig. 1).
The experiment was repeated three times to obtain
significant data for statistical analysis.
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Measurement of cell length
Cell-length measurements of all cell cultures supple-
mented with BSA, BSA/HCl, control and TGF-b2
were performed 12 h after cell seeding into the tissue
culture flasks. This time allowed for primary chon-
drocytes settling and attaching to the solid surface.
Recording of the cell length continued every 24 h.
A total of 30 randomly selected cells were imaged and
saved and their lengths measured using NIH Image J
software. As the primary chondrocytes were isolated
from different zones of cartilage they had different
shapes, and hence the largest dimension of the cells
was considered as the cell length. The average data
coming from repeated experiments were calculated
and set as average chondrocyte cell length. The mean
cell length and standard deviation with error bars were
calculated using Microsoft Excel. The standardised
cell lengths from each treatment were compared with
the standardised dimension of chondrocytes in the
control culture to find out whether or not TGF-b2
causes any change in the length of the cells.
Following standardisation of the data, the first
measurements were set as 100% and the subsequent
data were determined as percentage average.
Wound closure assay
All five chondrocyte cultures reached 100% conflu-
ency after 132 h.
The wound repair capacity of multilayer primary
chondrocyte culture was investigated using model
wound closure assay. A wound model was created by
scratching the cell layer using a fine-tip extended
transfer pipette of 1 mm diameter (Sigma Aldrich,
UK). Following scratching, wound width was mea-
sured via Image J software every 2 h at 10 different
points along the width until the wound was totally
healed except for the model wound treated with TGF-
b2, which did not fully heal during the experiment.
The re-identification of these points was achieved by
drawing 10 lines perpendicular to the scratch in the
cell layer on the underside of the culture flask with an
alcohol-resistant marker pen. Measurements of wound
width were then taken to the right of the point at which
each perpendicular line intersected with the model
wound. An average wound width of * 131.77 lm
was recorded and the normalized % model wound
closure was used to eliminate different wound width
along the wound bed, for future analysis regarding the
effect of different growth factor.
Primary chondrocyte detachment analysis
The strength of primary-chondrocyte attachment on
substrate in the presence of different supplementations
was analysed using the trypsinisation assay.
Trypsin is a temperature-dependent digestive
enzyme which breaks down the cell–extracellular
matrix and cell–cell binding proteins at the carboxyl
end (Sigma Aldrich, UK). The cleavage of adhesion
proteins results in cell detachment from substratum
and/or separation from other cells.
The assay was carried out at room temperature of
18 C. The media were aspirated from the tissue
culture flask and the flask was rinsed three times with
Fig. 1 The chondrocytes cultured in media with different
supplementations. The captured images are the first and last
pictures (scale bar 50 lm)
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Hank’s balanced salt solution (HBSS) to remove any
serum from the confluent layer of cells. After aspira-
tion of the last HBSS, 2 ml of trypsin was poured into
the culture flask to detach the cells from the culture
flask and their ECM. The protein digestion process
was imaged by phase-contrast microscope, with a
digital camera installed on the microscope, and Image
J (NIH) software. A sequence of 60 images with 10-s
time intervals were recorded and saved for further
analysis.
A total of 2 ml of serum containing media was
added to the cell suspension immediately after
detachment of the cell from the culture flask. After
trypsinization, the suspension was used for cell count.
The time taken for the chondrocytes to get a round
shape and shiny appearance, signs of detachment, was
recorded.
The recorded time was multiplied by 10, which was
the time interval, and then divided by 60 to obtain the
detachment time per second. The time taken for the
detaching of a cell in the control culture was converted
to percentage average as 100% and the other cell
cultures, containing different supplementations, were
compared against the control. Microsoft Excel was
used to calculate the mean, standard deviation and a
graph was then plotted to demonstrate % detachment
time for each supplementation (Fig. 2).
The final suspensions obtained from trypsinisation
were used to evaluate cell proliferation rate. This
proliferation rate was achieved by counting the
trypsinized cells and comparing with initial seeded
cells.
RNA extraction
Total RNA was extracted from primary chondrocyte
cultures using TRIzol Reagent (Invitrogen, UK).
Samples (2 lg) were treated with DNaseI and revers
transcribed in a 25 ll volume reaction using Super-
script II enzyme (Invitrogen, UK) and random
hexamer primers. Products were diluted 1:100 and
stored at - 20 C until used for RT-PCR (real time -
PCR).
RT-PCR
Primers were used at 5 lMwith 10 ll of SYBR Green
Master Mix (Thermo Fischer, UK) in final volume of
20 ll under the following condition: 95 C for 15 min
(denaturation), 45 cycles at 94 C for 15 s, 60 C for
20 s (annealing) and 72 C for 20 s (amplification).
PCR amplification and real-time fluorescence detec-
tion were performed by the Light Cycler version 1.0
detection system (Roche). Relative expression was
calculated according to the 2-D DCt method (Livak and
Schmittgen 2001) (Table 1).
Western blot analysis
Cells were rinsed, and scrapped in RIPA lysis buffer
(25 mM TrisHCl pH 7.6, 150 mM NaCl, 1% NP-40,
1% sodium deoxycholate, 0.1% SDS, Thermo Scien-
tific, UK), supplemented with phosphatase and pro-
tease inhibitors (Thermo Scientific Halt Protease
Inhibitor Cocktail, HaltTM Phosphatase Inhibitor
Fig. 2 Trypsinisation assay before (left) and after (right)
detachment (scale bar = 50 lm)
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Cocktail). The extracts (50 lg protein) were subjected
to fractionation in 10% SDS-PAGE, transferred to
polyvinylidene fluoride membranes (Kinesis, UK),
and reacted with TbRI, TbRII (1:500), Smad2/3 or
phospho-Smad2/3 polyclonal antibodies (1:1000)
(Thermo Fisher Scientific, UK). Blocking buffer was
added to each membrane and 0.5 lg/ml Pierce Goat
anti-Rabbit IgG Secondary Antibody Horseradish
Peroxidase (HRP) (Thermo Fisher, UK) was diluted
in the blocking buffer (1:3000). The signals were
revealed with SuperSignal West Pico Chemilumines-
cent Substrate (Thermo Fisher Scientific, UK) and
exposed to X-ray film. The membranes were also
reacted with anti b-actin to verify equal loading.
Statistical analysis
The effect of different supplementations in chondro-
cyte cell proliferation, cell length, adhesion, and
wound repair was statistically analysed by One-way
ANOVA test. This test was performed to evaluate the
statistically significant difference between the means
of the treatments. The difference between the means of
the treatments was assumed as Ha, and the similarity
was assumed as H0.
H0 : Mean1 ¼ Mean2 ¼ Mean3 ¼ Mean4
Statistical significance was determinated by student’s
test. p values less than 0.05 were considered
significant.
Results
Primary chondrocytes, cultured in multilayer in high-
glucose DMEM media supplemented with 10% FCS,
were used as control culture.
The evaluation of the effect of different supple-
mentations in chondrocyte proliferation showed that
the HCl induced cell proliferation at the highest level
(unpublished work) with 1026.23% increase (Fig. 3).
In contrast, TGF-b2 induced apoptosis rather than
proliferation. The cell density was lowered at 50.7%
when compared with control and the proliferation rate
was 2.33-fold. Unlike TGF-b2, HCl induced cell
proliferation at the highest level, which was 2.23-fold
more than control (Figs. 3, 4).
The cells treated with TGF-b2 developed a well-
spread fibroblastic shape acquiring a mean length of
14.20 lm in diameter. This indicates that TGF-b2
increases excessive synthesis of ECM proteins con-
clusion which are involved in the formation of
fibroblast-type morphology and consequently dedif-
ferentiation of chondrocyte in vitro. In comparison,
HCl (12.2 lm ± 0.002 SE), BSA (11.18 lm ± 0.002
SE), BSA/HCl (10.45 lm ± 0.002 SE) had no effect
on cell length and cells under these treatment regimens
resembled in the control treatment group (12.51 lm ±
0.002 SE). There was no recognisable difference in
Fig. 3 Graph of primary chondrocyte proliferation cultured in
DMEM media in various supplementations. Initial cell concen-
tration, which was 2.8 9 105 cells/ml, was set as 100%
Table 1 Utilized primers for RT-PCR amplification
Gene Forward primer Revers primer
Smad2 50-GCTGTTTTCCTAGCGTGGCTT-30 50-TCCAGACCCACCAGCTGACT-30
Smad3 50-GCATCAGCCGCTTCTCAAGT-30 50-ATCTCCCCACCATCACCTCC-30
Smad4 50-CCTTCTGGAGGAGATCGCT-30 50-TCAATGGCTTCTGTCCTGTGG-30
Smad7 50-AATGTGTTTTCTAGATTCCCAACTTCTT-30 50-CACTCTCGTCTTCTCCTCCCAGTA-30
TGF-b2 50-CAGCGCTACATCGATAGCAA-30 50-GGTCCTCAGTGTAGCCCAAG-30
TbRI 50-TTAAAAGGCGCAACCAAGAAC-30 50-GTGGTGATGAGCCCTTCGAT-30
TbRII 50-GACATCAATCTGAAGCATGAGAACA-30 50- GGCGGTGATCAGCCAGTATT-30
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cell morphology between HCl, BSA, BSA/HCl and
control (Fig. 4).
Another four culture environments with addition of
HCl, BSA, BSA/HCl and TGF-b2 were compared
against the control culture (Fig. 5).
Interestingly, each cell culture reached its largest
cell length after different times.
TGF-b2 increased the chondrocyte cell length up to
152.9% over a period of 132 h. This could be related to
an increase in the production of components of the
ECM, which in turn, via up or down regulation of
specific integrins, induced changes in chondrocyte
shape. It is well known that the cytoskeleton determi-
nes the cell shape by anchoring to the integrin via the
actin filament. ELISA could determine the type of
integrin binding to the ECM/ligands. In contrast, the
smallest cell length was observed in BSA/HCl
contained media with 112.85% increase and
10.45 lm. The average change of cells in their widest
dimension in control was 115.97% with 12.51 lm.
Only chondrocytes cultured in the TGF-b2 contained
medium demonstrated an almost constant increase in
cell length with all others showing irregular changes.
This is because of low-proliferation capacity of
chondrocyte in the presence of TGF-b2 as revealed
in determination of the effect of TGF-b2 on cell
proliferation. The initial cell density was set as 100%
and all other cultures were compared with this initial
setting. The proliferation rate of control culture was
460.35%, corresponding to a 4.6-fold increase in cell
density at the end of the experiment.
During 54 h model wound closure assay, only in
controls and HCl contained culture was the gap
completely closed (Fig. 6).
The fastest wound healing occurred in an acidic
medium with 10 ll 4 mM HCl. The application of
BSA/HCl/TGFb-2 and the application of BSA con-
taining media appeared to inhibit wound closure.
Initially, cell migration was detected circa 6 h after
scratching. This may suggest that the chondrocyte cell
requires a revitalisation time after mechanical stress in
the form of scratching.
The results of model wound closure assays were set
as a normalized percentage average. The outcomes
were used to plot a graph to demonstrate the compar-
ison of the wound closures of chondrocytes cultured in
multilayer with various supplementations. It can be
seen that the wound models of control and HCl
contained cultures were closed at a slower rate after
54 h and those supplemented with BSA (2.88 lm ±
0.4 SE), BSA/HCl (1.38 lm ± 0.4 SE), and TGF-b2
(0.33 lm ± 0.1 SE) closed completely, after 54 h but
at a faster rate, with almost complete closure (wound
closure * 98%) after* 30 h (Fig. 7).
Results from trypsinisation assay demonstrated the
time required for detachment of chondrocyte cells
from substrate and separation from each other. This
time shows the strength of cell-substrate and/or cell–
cell adhesion (Fig. 2).
Chondrocytes cultured in the presence of 1% v/v of
4 mM HCl were detached in 7.778 min, which
corresponds to being 6.87% longer than control
culture. This time for TGFb-2 was the lowest with
5.056 min, which caused the cells to detach 2.22 min
faster than the cells in the control culture. The cells in
Fig. 4 Culture of chondrocyte cells in high glucose DMEM
with different supplementations: aHCl; bBSA; cBSA/HCl, and
d BSA/HCl/TGF-b2 (scale bar = 50 lm)
Fig. 5 Graphs of primary chondrocyte cell length during 132-h
culture with various supplementations with standard error bar
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BSA and BSA/HCl contained mediums showed
recognisable reductions in detachment time of 5.94
and 6.05 min, respectively.
It can be seen that TGF-b2 addition resulted in
lower % detachment (* 70%) whereas the HCl
showed a similar result to control followed by BSA
and BSA/HCl additions with* 85% detachment.
The above set of experiments revealed that TGFb-2
has an inhibitory effect on chondrocyte cell prolifer-
ation and reduces cell density in the presence of 10%
FCS in planar culture system. This type of growth
factor induces an increase in cell length by synthesis of
Fig. 6 Microphotographs of wound closure assay for primary
chondrocyte: a control; bHCl; cBSA; dBSA/HCl, and e TGFb-
2.Multilayer cultures were scratched by tip of a plastic pipette of
1 mm and measured using image analysis software. An average
wound size of* 131.77 lmwas recorded after initial scratch at
0 h (scale bar = 50 lm)
Fig. 7 , Graph of wound closure for primary chondrocytes
cultured in BSA, BSA/HCl, HCl, and TGF-b2 contained media
and control
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extracellular matrix proteins and by stimulating the
cell to acquire fibroblastic morphology. Excessive
ECM molecules capture a large area in the culture
flask and consequently cause the cells to spread well in
multilayer with weak cell adhesion ability. In contrast,
1% v/v 4 mM HCl contained media promoted cell
proliferation up to 10.12-fold, which is very close to
the required cell density for ACI.
The results of statistical analysis revealed that the
null hypothesis was rejected in all tests, as in all tests
the F[ Fcrit and the p\ 0.05, except for wounds
repair, which showed that the model wounds on the
chondrocyte multilayers with different supplementa-
tions were almost similar in terms of wound closure
response even after 54 h (Fig. 7).
We investigated the effect of TGF-b2 on mRNA
expression of TGF-b signalling genes in a dose-
dependent manner, using real-time RT-PCR. A 48-h
incubation with TGF-b2 significantly reduced the
expression of both TGF-b receptors and Smad3,
whereas the Smad7 mRNA level was increased. No
significant effect was observed on Smad2 and Smad4
(Fig. 8a).
A time-course study revealed that, at mRNA levels,
TGF-b2 quickly upregulates its own receptors and
Smad3, since it increases their expression as soon as
30 min of treatment. For longer treatments, TGF-b2
exerted the opposite effect and downregulated TGF-b
receptors (after 24 h of incubation) as well as Smad3
(after 3 h of incubation). Independent from incubation
time the expression of Smad7 was upregulated by
TGF-b2 (Fig. 8a).
Furthermore, western blot analysis showed that
TbRII is downregulated after 24 h whereas TbRI
protein expression is decreased as soon as 1 h after
TGFb2 treatment. In addition, as expected, TGF-b2
induced Smad2/3 phosphorylation. Expression of
actin filament was slightly increased at the presence
of TGF-b2 (Fig. 8b).
Modifications of gene expression under TGF-b2
treatment could be due to an increased degradation
rate and/or a reduced transcription. Inhibition of de
novo transcription clearly showed that TGF-b2
reduced the mRNA half-life of both TGF-b receptors.
Indeed, the TbRI half-life is about 20 min but was
reduced to 10 min when chondrocytes were incubated
with TGF-b2, and the TbRII mRNA half-life is
45 min for control cells and was reduced by almost
80% after TGF-b2 treatment.
Discussion
Cartilage, a highly specialized tissue, sustains com-
pressive load by cushioning the bones at joints, and by
providing almost frictionless condition for joints to
reduce wear. Cartilage as an avascular tissue has poor
repair capacity and thus any damage or degradation on
this tissue can cause pain, complexity in mobility and
adversely affect daily life.
Monolayer culture of the primary chondrocyte
resulted in dedifferentiation of cells and production
of stress fibers. This characteristic was prevented by
3D chondrocyte culture (Multilayer Culture).
To our knowledge, so far, there are only few
surgical options for treatment of chondral or osteo-
chondral lesions of the hip. One such treatment is that
of ACI which has been used frequently for treatment
of knee cartilage defects with good outcomes, but
there is probably only one or no use of ACI for the hip.
It is our recommendation that collagen (type-I) gel (or
patches) be used for prior chondrocyte implantation.
Another application of this research output/findings
is 3D scaffold design which is a critical and essential
part of tissue engineering. Our results from detach-
ment assay suggested clearly that TGF-b2 will
decrease mechanical strength and biological interac-
tions of chondrocyte culture, but it could have
different effect when manipulated with other proteins.
TGF-b2 increased cell length of chondrocyte, but
decreased its proliferation rate and the wound healing
process. TGF-b2 also decreased cell adhesion ability
to the surface of the culture flask which could be a sign
of decrease in cell anchoring agent/ligands and
proteins required to cell–cell and cell–ECM adhesion.
Our research shows that TGF-b2 exerts a differen-
tial effect on the transcription of genes implicated in
the Smads pathway. While TGF-b2 upregulates its
receptors and Smad3 for short incubation (at least at
mRNA level), it downregulates them in the long term.
In addition, it upregulates Smad7 and does not
significantly alter Smad2 and Smad4 expression. This
positive and negative feedback loop of the TGF-b2
pathway induces differential response of chondrocytes
to TGF-b2. The mechanisms responsible for modula-
tion of Smads and for TGF-b receptor expression seem
to be different.
We have established that, in primary chondrocytes,
TGF-b2 acts, at least in part, by strongly decreasing
the mRNA stability of its receptors. This rapid
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turnover potentially allows the receptor rate to change
rapidly in response to its own ligand. We cannot,
however, exclude the possibility that TGF-b down-
regulates its receptors also at the transcriptional and
translational levels.
Concerning Smad effectors, we established that the
downregulation of Smad3 mRNA expression in TGF-
b2 treated chondrocytes was not due to decreased
transcript stability, suggesting a transcriptional effect
of TGF-b2.
In contrast to Smad3, Smad7 mRNA expression
was rapidly and markedly induced by TGF-b2.
Increased expression of the inhibitor Smad7 has been
associated with inhibition of TGF-b signaling. Smad7
could negatively regulate TGF-b signaling; on one
hand by inhibiting R-Smad activation by TbRI or by
enhancing TbRI degradation in the cytoplasm, and on
the other hand by disrupting the formation of the TGF-
b induced functional Smad-DNA complex in the
nucleus (Zhang et al. 2007). These TGF-b2 induced
Fig. 8 Effect of TGF-b2 on expression of TbRI, TbRII,
Smad2/3, actin and phosphorylated Smad2/3 protein analysed
by RT-PCR and western blot technique. a Articular cartilage
chondrocytes were incubated with 5 ng/ml TGF-b2 for different
times. At the end of incubations, TbRI, TbRII, Smad3 and
Smad7 mRNA levels were assayed by RT-PCR. b In addition,
TbRI, TbRII, Smad2/3 and phosphorylated Smad2/3 protein
expression were analyzed by western blot analysis. As control
for equal loading, b-actin was also run in each blot. The
modulation of mRNA expression was expressed as the
percentage of controls after normalisation to the GAPDH signal
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modifications on expression of TGF-b receptors and
Smads may participate in the chondrocyte-phenotype
changes observed in a pathology associated, at least in
the first stage, with an increase in the TGF-b2 level.
Conclusions
This work clearly demonstrated a successful and
typical cell engineering of chondrocyte multilayers
with our own model using isolated primary RAC by
cell seeding, multiple 2D cell expansion and differen-
tiation in vitro and without the use of bioreactor.
Therefore, the same model can be used for isolation of
HAC from clinically approved human biopsies for
autologous chondrocyte implantation, and/or multi-
layer production for, e.g. cytotoxicity tests. Our model
can also be used for direct expansion of the limited
number of chondrocytes obtained from RAC or HAC,
reaching higher densities similar to those used in
conventional cartilage tissue engineering based on
cells expanded by 2D cultures.
The effect of manipulated TGF-b2 with other
growth factors and/or proteins needs to be investigated
to finalize the utilization of this growth factor and
design of scaffolding in treatment of different types of
arthritis.
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